Physician
Psychiatry
Dr. A L. Harris, MD
|
|
Give Review
Dr. A L. Harris works in the field of Psychiatry. She graduated from Eastern Virginia Medical School. Harris is a published MD. She published 101 publications, including: 'Direct high affinity modulation of connexin channel activity by cyclic nucleotides.'
Publications
- Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α.
- Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
- Copper chelation as an antiangiogenic therapy.
- Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.
- Hypoxia-induced pathways in breast cancer.
- Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
- Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
- Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and t...
- Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
- HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors.
- Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carci...
- Detection of mammaglobin mRNA in the plasma of breast cancer patients.
- Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
- Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel den...
- Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy.
- Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
- Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
- Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in huma...
- Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
- Association of ARNT splice variants with estrogen receptor-negative breast cancer, poor induction of vascular endothelial growth factor under hypoxia, and poor prognosis.
- Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.
- Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.
- Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.
- Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
- Give CNAs a career ladder to climb.
- Exploring hemichannel permeability in vitro.
- Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast ca...
- Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
- A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.
- A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
- Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
- The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
- A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.
- The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.
- Role of matrix metalloproteinase 9 in pituitary tumor behavior.
- Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
- Cid1, a fission yeast protein required for S-M checkpoint control when DNA polymerase delta or epsilon is inactivated.
- Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
- Angiogenesis in pituitary adenomas and the normal pituitary gland.
- Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
- Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor.
- More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
- c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.
- von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy.
- From hyperplasia to neoplasia and invasion: angiogenesis in the colorectal adenoma-carcinoma model.
- Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
- Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence.
- Different ionic selectivities for connexins 26 and 32 produce rectifying gap junction channels.
- Macrophage responses to hypoxia: relevance to disease mechanisms.
- Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.
- Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
- Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
- Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
- Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects.
- Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma.
- Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer.
- Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates.
- Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
- Regulation of connexin channels by pH. Direct action of the protonated form of taurine and other aminosulfonates.
- Direct high affinity modulation of connexin channel activity by cyclic nucleotides.
- Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
- Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
- Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.
- Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitro.
- New developments in angiogenesis: a major mechanism for tumor growth and target for therapy.
- The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target.
- Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell...
- Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules.
- Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer.
- Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery.
- Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
- A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors.
- Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
- Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit.
- Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.
- Expression of Wnt5a is downregulated by extracellular matrix and mutated c-Ha-ras in the human mammary epithelial cell line MCF-10A.
- cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27, and expression in human breast and colon carcinomas.
- Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.
- Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.
- Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence.
- Targeting gene expression to hypoxic tumor cells.
- The epidermal growth factor receptor in breast cancer.
- Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived e...
- The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown i...
- Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.
- Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.
- Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
- Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers.
- Compartment switching of WNT-2 expression in human breast tumors.
- Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
- Channel-forming activity of immunoaffinity-purified connexin32 in single phospholipid membranes.
- Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.
- Microvessel count predicts survival in uveal melanoma.
- Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients.
- The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers.
- Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.
- Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma tre...
- Mechanisms and therapeutic implications of angiogenesis.
- Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
- The distribution of the deleted in colon cancer (DCC) protein in human tissues.
Schools
Eastern Virginia Medical School
University Oreg Health Scis
Good Samaritan Regional Med Center
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Banner Good Samaritan Medical Center -
Oregon Health & Science University -
Eastern Virginia Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. Eva B. McCullars, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia A. Fangohr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ewa M. Szafraniec, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hilda S. Amato, MD |
|
|
Dr. Sophia Kang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devnandini C. Rastogi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramasubramaniam Venkatabalaji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl A. Hammerschlag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilhan Conklu, MD |